UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

N-myc and noncoding RNAs in neuroblastoma

Molecular cancer research, 2012-10, Vol.10 (10), p.1243-1253

2012

Volltextzugriff (PDF)

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma

Cancer informatics, 2019, Vol.18, p.1176935119832910-1176935119832910

2019

Volltextzugriff (PDF)

MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells

Proceedings of the National Academy of Sciences - PNAS, 2013-06, Vol.110 (25), p.10258-10263

2013

Volltextzugriff (PDF)

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors

Frontiers in oncology, 2021-11, Vol.11, p.803443-803443

2021

Volltextzugriff (PDF)

MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma

Carcinogenesis (New York), 2011-07, Vol.32 (7), p.1005-1012

2011

Volltextzugriff (PDF)

Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells

Frontiers in pediatrics, 2023-03, Vol.11, p.1098999-1098999

2023

Volltextzugriff (PDF)

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma

BMC developmental biology, 2011-01, Vol.11 (1), p.1-1, Article 1

2011

Volltextzugriff (PDF)

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

Nature communications, 2015-11, Vol.6 (1), p.8904, Article 8904

2015

Volltextzugriff (PDF)

A conformational switch in the DiGIR1 ribozyme involved in release and folding of the downstream I-DirI mRNA

RNA (Cambridge), 2009-05, Vol.15 (5), p.958-967

2009

Volltextzugriff (PDF)

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma

British journal of cancer, 2011-07, Vol.105 (2), p.296-303

2011

Volltextzugriff (PDF)

Short-term sequence evolution and vertical inheritance of the Naegleria twin-ribozyme group I intron

BMC evolutionary biology, 2006-05, Vol.6, p.39

2006

Volltextzugriff (PDF)

Twelve Group I introns in the same pre-rRNA transcript of the myxomycete Fuligo septica: RNA processing and evolution

Molecular biology and evolution, 2004-07, Vol.21 (7), p.1283-1293

2004

Volltextzugriff (PDF)

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

Oncogene, 2019-04, Vol.38 (15), p.2800-2813

2019

Volltextzugriff (PDF)

MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1 , MCL-1 and MYCN

Oncotarget, 2018-04, Vol.9 (26), p.18160-18179

2018

Volltextzugriff (PDF)

Hsa-miR-376c-3p targets Cyclin D1 and induces [G.sub.1]-cell cycle arrest in neuroblastoma cells

Oncology letters, 2018-11, Vol.16 (5), p.6786

2018

Volltextzugriff (PDF)

Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs

Anticancer research, 2015-05, Vol.35 (5), p.2521-2530

2015

Volltextzugriff (PDF)

Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells

Oncology letters, 2018-11, Vol.16 (5), p.6786-6794

2018

Volltextzugriff (PDF)

Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment

Cancer letters, 2016-03, Vol.372 (1), p.128-136

2016

Volltextzugriff (PDF)

Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells

Differentiation (London), 2011, Vol.81 (1), p.25-34

2011

Volltextzugriff (PDF)

Molecular modelling of the GIR1 branching ribozyme gives new insight into evolution of structurally related ribozymes

The EMBO journal, 2008-02, Vol.27 (4), p.667-678

2008

Volltextzugriff (PDF)

Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines

Nucleic acids research, 2007-05, Vol.35 (9), p.e67

2007

Volltextzugriff (PDF)

The ability to form full-length intron RNA circles is a general property of nuclear group I introns

RNA (Cambridge), 2003-12, Vol.9 (12), p.1464-1475

2003

Volltextzugriff (PDF)

A conformational switch in the DiGIR1 ribozyme involved in release and folding of the downstream I- Dir I mRNA

RNA (Cambridge), 2009-05, Vol.15 (5), p.958-967

2009

Volltextzugriff (PDF)

Wnt/[beta]-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

Nature communications, 2015-11, Vol.6, p.8904

2015

Volltextzugriff (PDF)

DiGIR1 and NaGIR1: naturally occurring group I-like ribozymes with unique core organization and evolved biological role

Biochimie, 2002-09, Vol.84 (9), p.905-912

2002

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

N-myc and noncoding RNAs in neuroblastoma

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma

MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors

MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma

Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

A conformational switch in the DiGIR1 ribozyme involved in release and folding of the downstream I-DirI mRNA

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma

Short-term sequence evolution and vertical inheritance of the Naegleria twin-ribozyme group I intron

Twelve Group I introns in the same pre-rRNA transcript of the myxomycete Fuligo septica: RNA processing and evolution

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1 , MCL-1 and MYCN

Hsa-miR-376c-3p targets Cyclin D1 and induces [G.sub.1]-cell cycle arrest in neuroblastoma cells

Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs

Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells

Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment

Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells

Molecular modelling of the GIR1 branching ribozyme gives new insight into evolution of structurally related ribozymes

Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines

The ability to form full-length intron RNA circles is a general property of nuclear group I introns

A conformational switch in the DiGIR1 ribozyme involved in release and folding of the downstream I- Dir I mRNA

Wnt/[beta]-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

DiGIR1 and NaGIR1: naturally occurring group I-like ribozymes with unique core organization and evolved biological role

Suchergebnisse filtern